Aviragen Therapeutics competitors

Aviragen Therapeutics Competitors include Oxis International, Inovio Pharmaceuticals, Flexion Therapeutics and Vertex Pharmaceuticals.
Add company...
Aviragen Therapeutics
Aviragen Therapeutics is focused on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic options and affect a significant number of patients globally.
Oxis International
Oxis International, Inc. through its wholly owned subsidiary Oxis Biotech, Inc., is engaged in the developement of immunotherapies for cancer treatment.
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.
Flexion Therapeutics
Flexion Therapeutics is a biotechnology company that develops long-lasting intra-articular injection therapies to treat osteoarthritis.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Founding Date
Founding Date
1969
Founding Date
1965
Founding Date
1979
Founding Date
2007
Founding Date
1989
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Alpharetta, US HQ
Locations
Tampa, US HQ
Locations
Blue Bell, US HQ
San Diego, US
San Diego, US
Locations
Burlington, US HQ
Locations
Boston, US HQ
Employees
Employees
21
Employees
N/A
Employees
27816% increase
Employees
95
Employees
2,300
Valuation ($)
Valuation ($)
24 m
Valuation ($)
1.5 k
Valuation ($)
468.2 m
Valuation ($)
613.7 m
Valuation ($)
42.1 b
Facebook likes
Facebook likes
N/A
Facebook likes
222
Facebook likes
265
Facebook likes
N/A
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
73
Twitter followers
7 k
Twitter followers
527
Twitter followers
32.9 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$42.2m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$2.5b (FY, 2017)
Net income
Net income
N/A
Net income
($143.2m) (FY, 2017)
Net income
($88.2m) (FY, 2017)
Net income
($137.5m) (FY, 2017)
Net income
$91.6m (FY, 2017)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
2 (FY, 2016)
Patents Issued
620 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.4m
Total funding raised
$ 63.3m
Total funding raised
$ 107m
Total funding raised
$ 2.4m
For sources of this data, please see the company profileDownload Excel

View company profiles

Oxis International
HQ
Tampa, US

Oxis International, Inc. through its wholly owned subsidiary Oxis Biotech, Inc., is engaged in the developement of immunotherapies for cancer treatment.

View company
Inovio Pharmaceuticals
HQ
Blue Bell, US
Employees
278↑ 16% increase

Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.

View company
Flexion Therapeutics
HQ
Burlington, US
Employees
95

Flexion Therapeutics is a biotechnology company that develops long-lasting intra-articular injection therapies to treat osteoarthritis.

View company
Vertex Pharmaceuticals
HQ
Boston, US
Employees
2,300

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

View company